Although the median values of CSF β-syn showed an increasing trend along with the prolongation of clinical duration, no statistical difference was observed among patients with survival times of less than 3 months, between 3 and 5 months, and longer than 5 months.
← all excerpts
β-synuclein in cerebrospinal fluid as a potential biomarker for distinguishing human prion diseases from Alzheimer's and Parkinson's disease.
1
—
—